Abstract | AIMS OF THE STUDY: We recently reported the potential antioxidant and anti-inflammatory activities of umbelliferone 6-carboxylic acid (UMC) isolated from the whole plants of Angelica decursiva. In this study, we elucidated the anti-inflammatory mechanisms of UMC in vitro and in vivo. METHODS: RESULTS: UMC dose-dependently inhibited NO and PGE(2) production by down-regulating iNOS and COX-2 protein expression in LPS-stimulated RAW 264.7 macrophages. UMC also suppressed the production of the proinflammatory cytokine TNF-α in LPS stimulated RAW 264.7 cells in a concentration dependent manner. In addition, UMC dose-dependently prevented LPS-induced nuclear translocation of NF-κB in RAW 264.7 macrophages. Furthermore, UMC exhibited the inhibitory activity against t-BHP-induced ROS generation in RAW 264.7 cells with an IC(50) value of 705.1 μg/ml. Moreover, UMC inhibited λ- carrageenan induced mouse paw edema by 70.40 and 60.20% at doses of 50 and 25 mg/kg body weight, respectively. CONCLUSION: The combined results of this study indicate that UMC is an important anti-inflammatory constituent of A. decursiva and its anti-inflammatory effect was due to its ability to inhibit the production of inflammatory mediators via inhibition of NF-κB activation pathway.
|
Authors | Md Nurul Islam, Ran Joo Choi, Seong Eun Jin, Yeong Shik Kim, Bo Ra Ahn, Dafang Zhao, Hyun Ah Jung, Jae Sue Choi |
Journal | Journal of ethnopharmacology
(J Ethnopharmacol)
Vol. 144
Issue 1
Pg. 175-81
(Oct 31 2012)
ISSN: 1872-7573 [Electronic] Ireland |
PMID | 22981803
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2012 Elsevier Ireland Ltd. All rights reserved. |
Chemical References |
- Anti-Inflammatory Agents
- Lipopolysaccharides
- NF-kappa B
- Tumor Necrosis Factor-alpha
- Umbelliferones
- umbelliferone 6-carboxylic acid
- Nitric Oxide
- Carrageenan
- Nitric Oxide Synthase Type II
- Nos2 protein, mouse
- Ptgs2 protein, mouse
- Cyclooxygenase 2
- Dinoprostone
|
Topics |
- Angelica
- Animals
- Anti-Inflammatory Agents
(pharmacology, therapeutic use)
- Carrageenan
- Cell Line
- Cyclooxygenase 2
(metabolism)
- Dinoprostone
(metabolism)
- Edema
(chemically induced, drug therapy, pathology)
- Inflammation
(metabolism)
- Lipopolysaccharides
- Male
- Mice
- Mice, Inbred ICR
- NF-kappa B
(antagonists & inhibitors, metabolism)
- Nitric Oxide
(metabolism)
- Nitric Oxide Synthase Type II
(metabolism)
- Phytotherapy
- Tumor Necrosis Factor-alpha
(metabolism)
- Umbelliferones
(pharmacology, therapeutic use)
|